THE EFFECT OF THE CHOLECYSTOKININ RECEPTOR ANTAGONIST MK-329 ON MEAL-STIMULATED PANCREATICOBILIARY OUTPUT IN HUMANS

被引:56
|
作者
CANTOR, P
MORTENSEN, PE
MYHRE, J
GJORUP, I
WORNING, H
STAHL, E
SURVILL, TT
机构
[1] RIGSHOSP,DEPT CLIN CHEM & SURG GASTROENTEROL C,DK-2100 COPENHAGEN,DENMARK
[2] GLOSTRUP UNIV HOSP,DEPT MED GASTROENTEROL,GLOSTRUP,DENMARK
关键词
D O I
10.1016/0016-5085(92)91738-P
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
To determine the physiological role of circulating cholecystokinin (CCK), the effect of the CCK receptor antagonist MK-329 on upper digestive processes was investigated in six normal volunteers after a mixed meal. In a double-blind, two-period, randomized crossover design, the subjects received either 10 mg MK-329 or placebo orally 3 hours 15 minutes before the meal, which contained 51CrCl3 as food marker. A five-lumen tube with the tip in the distal duodenum allowed continuous marker infusion (57Co-B12) and duodenal aspiration as well as recordings of antral and duodenal motility patterns via three pressure sensors. Postprandially, MK-329 caused a significant reduction of 30%-60% (P < 0.05) in pancreatic trypsin output during the initial three 15-minute periods; thereafter, the output was virtually the same than after placebo. Thus, the integrated enzyme response was only reduced by 15% (NS) during the 3-hour period beginning 15 minutes after the meal. In contrast, gallbladder contraction, determined by total bile acid excretion, was inhibited by 77% (P < 0.05), indicating a crucial role of CCK in regulating gallbladder motility. Except for the initial 30 minutes postprandially, MK-329 also induced a significant reduction in duodenal pH with mean values ranging from 3.5 ± 0.2 to 4.1 ± 0.3 compared with 4.5 ± 0.3 to 5.0 ± 0.4 after placebo (P < 0.05), probably because of lowered secretion of pancreatic bicarbonate. Gastric emptying rate was significantly accelerated by MK-329 during the initial 75 minutes after the meal, but the time for 50% emptying did not differ from placebo [127.5 ± 7.7 vs. 140.0 ± 9.0 minutes (NS)]. No changes were observed in the motility pattern of the proximal duodenum after feeding. Whereas MK-329 only caused a slight increase of the basal plasma CCK concentrations, the postprandial levels were markedly enhanced. Peak concentrations were 10.0 ± 1.3 vs. 4.0 ± 0.5 pmol/L after placebo (P < 0.001), and the integrated response exceeded the control value by 175% (P < 0.01). The results suggest that circulating CCK is not an essential mediator of the postprandial pancreatic enzyme secretion in humans, whereas it plays a critical role in gallbladder emptying. © 1992.
引用
收藏
页码:1742 / 1751
页数:10
相关论文
共 49 条
  • [41] EFFECT OF RIOPROSTIL, A SYNTHETIC PROSTAGLANDIN-E1 ON MEAL-STIMULATED GASTRIC-ACID SECRETION AND PLASMA GASTRIN-LEVELS IN HUMANS
    SCHULTE, K
    SINGER, MV
    EYSSELEIN, V
    DEMOL, P
    GOEBELL, H
    DIGESTION, 1987, 36 (03) : 162 - 167
  • [42] EFFECT OF THE SPECIFIC CHOLECYSTOKININ-RECEPTOR ANTAGONIST LOXIGLUMIDE ON BOMBESIN STIMULATED PANCREATIC-ENZYME SECRETION IN MAN
    JEBBINK, MCW
    JANSEN, JBMJ
    MOOY, DM
    ROVATI, LC
    LAMERS, CBHW
    REGULATORY PEPTIDES, 1991, 32 (03) : 361 - 368
  • [43] EFFECTS OF THE 5-HYDROXYTRYPTAMINE 3-RECEPTOR ANTAGONIST ICS 205-930 ON FASTING AND ON MEAL-STIMULATED AND NEOSTIGMINE-STIMULATED COLONIC MOTOR-ACTIVITY IN HEALTHY MAN
    STACHER, G
    SCHNEIDER, C
    ABATZI, TA
    STACHERJANOTTA, G
    GAUPMANN, G
    MITTELBACH, G
    STEINRINGER, H
    GASTROENTEROLOGY, 1988, 94 (05) : A440 - A440
  • [44] THE 5-H DROXYTRYPTAMINE3, RECEPTOR ANTAGONIST, ICS 205-930 (ICS), INCREASES FASTING AS WELL AS MEAL-STIMULATED AND NEOSTIGMINE-STIMULATED COLONIC MOTOR-ACTIVITY
    STACHER, G
    SCHNEIDER, G
    ABATZI, TA
    STACHERJANOTTA, G
    GAUPMANN, G
    MITTELBACH, G
    STEINRINGER, H
    HEPATO-GASTROENTEROLOGY, 1988, 35 (04) : 195 - 195
  • [45] Effect of lintitript, a new CCK-A receptor antagonist, on gastric emptying of a solid-liquid meal in humans
    Kreiss, C
    Schwizer, W
    Borovicka, J
    Jansen, JBMJ
    Bouloux, C
    Pignol, R
    Delaloye, AB
    Fried, M
    REGULATORY PEPTIDES, 1998, 74 (2-3) : 143 - 149
  • [46] EFFECT OF THE CHOLECYSTOKININ-RECEPTOR ANTAGONIST LORGLUMIDE ON PANCREATIC-ENZYME SECRETION STIMULATED BY BOMBESIN, FOOD, AND CERULEIN, GIVING SIMILAR PLASMA CHOLECYSTOKININ CONCENTRATIONS IN THE DOG
    DEJONG, AJL
    SINGER, MV
    JANSEN, JBMJ
    NIEBEL, W
    ROVATI, LC
    LAMERS, CBHW
    GUT, 1991, 32 (02) : 215 - 219
  • [47] EFFECT OF A LOW-DOSE OF INTRADUODENAL FAT ON SATIETY IN HUMANS - STUDIES USING THE TYPE-A CHOLECYSTOKININ RECEPTOR ANTAGONIST LOXIGLUMIDE
    LIEVERSE, RJ
    JANSEN, JBMJ
    MASCLEE, AAM
    ROVATI, LC
    LAMERS, CBHW
    GUT, 1994, 35 (04) : 501 - 505
  • [48] EFFECT OF PROGLUMIDE, A CHOLECYSTOKININ RECEPTOR ANTAGONIST, ON CAERULEIN-STIMULATED PANCREATIC-ENZYME SECRETION AND PANCREATIC-POLYPEPTIDE RELEASE IN THE DOG
    FRIED, M
    BEGLINGER, C
    KOEHLER, E
    WHITEHOUSE, I
    VARGA, L
    GYR, K
    REGULATORY PEPTIDES, 1984, 8 (02) : 117 - 122
  • [49] EFFECT OF SR27897B, A NEW CCK-A RECEPTOR ANTAGONIST, ON GASTRIC-EMPTYING OF A SOLID-LIQUID MEAL IN HUMANS
    KREISS, C
    SCHWIZER, W
    BOROVICKA, J
    JANSEN, JBMJ
    BOULOUX, C
    PIGNOL, R
    BISCHOFDELALOYE, A
    FRIED, M
    GASTROENTEROLOGY, 1995, 108 (04) : A632 - A632